Literature DB >> 19654554

The major histocompatibility complex conserved extended haplotype 8.1 in AIDS-related non-Hodgkin lymphoma.

Brahim Aissani1, Kisani M Ogwaro, Sadeep Shrestha, Jianming Tang, Elizabeth C Breen, Hui-Lee Wong, Lisa P Jacobson, Charles S Rabkin, Richard F Ambinder, Otoniel Martinez-Maza, Richard A Kaslow.   

Abstract

BACKGROUND: Two single nucleotide polymorphisms (SNPs) in adjacent genes, lymphotoxin alpha (LTA +252G, rs909253 A>G) and tumor necrosis factor (TNF -308A, rs1800629 G>A), form the G-A haplotype repeatedly associated with increased risk of non-Hodgkin lymphoma (NHL) in individuals uninfected with HIV-1. This association has been observed alone or in combination with human leukocyte antigens HLA-B*08 or HLA-DRB1*03 in the major histocompatibility complex (MHC). Which gene variant on this highly conserved extended haplotype (CEH 8.1) in whites most likely represents a true etiologic factor remains uncertain.
OBJECTIVE: We aimed to determine whether the reported association of the G-A haplotype of LTA-TNF with non-AIDS NHL also occurs with AIDS-related NHL.
METHODS: SNPs in LTA and TNF and in 6 other genes nearby were typed in 140 non-Hispanic European American pairs of AIDS-NHL cases and matched controls selected from HIV-infected men in the Multicenter AIDS Cohort Study.
RESULTS: The G-A haplotype and a 4-SNP haplotype in the neighboring gene cluster (rs537160 (A) rs1270942 (G), rs2072633 (A), and rs6467 (C)) were associated with AIDS-NHL (odds ratio = 2.7, 95% confidence interval: 1.5 to 4.8, P = 0.0009; and odds ratio = 3.2, 95% confidence interval: 1.6 to 6.6, P = 0.0008; respectively). These 2 haplotypes occur in strong linkage disequilibrium with each other on CEH 8.1.
CONCLUSION: The CEH 8.1-specific haplotype association of MHC class III variants with AIDS-NHL closely resembles that observed for non-AIDS NHL. Corroboration of an MHC determinant of AIDS and non-AIDS NHL alike would imply an important pathogenetic mechanism common to both.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19654554      PMCID: PMC3015185          DOI: 10.1097/QAI.0b013e3181b017d5

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  47 in total

1.  Genomic control for association studies.

Authors:  B Devlin; K Roeder
Journal:  Biometrics       Date:  1999-12       Impact factor: 2.571

2.  Efficiency and power in genetic association studies.

Authors:  Paul I W de Bakker; Roman Yelensky; Itsik Pe'er; Stacey B Gabriel; Mark J Daly; David Altshuler
Journal:  Nat Genet       Date:  2005-10-23       Impact factor: 38.330

3.  Multi-SNP analysis of MHC region: remarkable conservation of HLA-A1-B8-DR3 haplotype.

Authors:  Theresa A Aly; Elise Eller; Akane Ide; Katherine Gowan; Sunanda R Babu; Henry A Erlich; Marian J Rewers; George S Eisenbarth; Pamela R Fain
Journal:  Diabetes       Date:  2006-05       Impact factor: 9.461

4.  Toward understanding MHC disease associations: partial resequencing of 46 distinct HLA haplotypes.

Authors:  Wade P Smith; Quyen Vu; Shuying Sue Li; John A Hansen; Lue Ping Zhao; Daniel E Geraghty
Journal:  Genomics       Date:  2006-01-23       Impact factor: 5.736

Review 5.  Altered immunity as a risk factor for non-Hodgkin lymphoma.

Authors:  Andrew E Grulich; Claire M Vajdic; Wendy Cozen
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2007-03-02       Impact factor: 4.254

6.  Tumour necrosis factor (TNF) gene polymorphism influences TNF-alpha production in lipopolysaccharide (LPS)-stimulated whole blood cell culture in healthy humans.

Authors:  E Louis; D Franchimont; A Piron; Y Gevaert; N Schaaf-Lafontaine; S Roland; P Mahieu; M Malaise; D De Groote; R Louis; J Belaiche
Journal:  Clin Exp Immunol       Date:  1998-09       Impact factor: 4.330

Review 7.  Tumor necrosis factor-alpha in the pathogenesis and treatment of cancer.

Authors:  G Mark Anderson; Marian T Nakada; Mark DeWitte
Journal:  Curr Opin Pharmacol       Date:  2004-08       Impact factor: 5.547

8.  Human leukocyte antigens class II and tumor necrosis factor genetic polymorphisms are independent predictors of non-Hodgkin lymphoma outcome.

Authors:  Przemyslaw Juszczynski; Ewa Kalinka; Jacques Bienvenu; Grzegorz Woszczek; Maciej Borowiec; Tadeusz Robak; Marek Kowalski; Ewa Lech-Maranda; Lucile Baseggio; Bertrand Coiffier; Gilles Salles; Krzysztof Warzocha
Journal:  Blood       Date:  2002-10-15       Impact factor: 22.113

9.  Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation.

Authors:  A G Wilson; J A Symons; T L McDowell; H O McDevitt; G W Duff
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-01       Impact factor: 11.205

10.  Complete MHC haplotype sequencing for common disease gene mapping.

Authors:  C Andrew Stewart; Roger Horton; Richard J N Allcock; Jennifer L Ashurst; Alexey M Atrazhev; Penny Coggill; Ian Dunham; Simon Forbes; Karen Halls; Joanna M M Howson; Sean J Humphray; Sarah Hunt; Andrew J Mungall; Kazutoyo Osoegawa; Sophie Palmer; Anne N Roberts; Jane Rogers; Sarah Sims; Yu Wang; Laurens G Wilming; John F Elliott; Pieter J de Jong; Stephen Sawcer; John A Todd; John Trowsdale; Stephan Beck
Journal:  Genome Res       Date:  2004-05-12       Impact factor: 9.043

View more
  15 in total

Review 1.  Cancer biomarkers in HIV patients.

Authors:  Richard F Ambinder; Kishor Bhatia; Otoniel Martinez-Maza; Ronald Mitsuyasu
Journal:  Curr Opin HIV AIDS       Date:  2010-11       Impact factor: 4.283

2.  Exome-wide analyses identify low-frequency variant in CYP26B1 and additional coding variants associated with esophageal squamous cell carcinoma.

Authors:  Jiang Chang; Rong Zhong; Jianbo Tian; Jiaoyuan Li; Kan Zhai; Juntao Ke; Jiao Lou; Wei Chen; Beibei Zhu; Na Shen; Yi Zhang; Ying Zhu; Yajie Gong; Yang Yang; Danyi Zou; Xiating Peng; Zhi Zhang; Xuemei Zhang; Kun Huang; Tangchun Wu; Chen Wu; Xiaoping Miao; Dongxin Lin
Journal:  Nat Genet       Date:  2018-01-29       Impact factor: 38.330

Review 3.  HIV-associated immune dysfunction and viral infection: role in the pathogenesis of AIDS-related lymphoma.

Authors:  Marta Epeldegui; Elena Vendrame; Otoniel Martínez-Maza
Journal:  Immunol Res       Date:  2010-12       Impact factor: 2.829

4.  Structure of tumor necrosis factor-alpha haploblocks in European populations.

Authors:  Aimee M Merino; Kui Zhang; Richard A Kaslow; Brahim Aissani
Journal:  Immunogenetics       Date:  2013-04-12       Impact factor: 2.846

5.  Positive association between lymphotoxin-alpha variation rs909253 and cancer risk: a meta-analysis based on 36 case-control studies.

Authors:  Xi Yu; Yi Huang; Changhong Li; Hailian Yang; Caide Lu; Shiwei Duan
Journal:  Tumour Biol       Date:  2013-10-18

6.  Pandemic influenza A/H1N1 virus infection and TNF, LTA, IL1B, IL6, IL8, and CCL polymorphisms in Mexican population: a case-control study.

Authors:  Guadalupe Morales-García; Ramcés Falfán-Valencia; Román Alejandro García-Ramírez; Ángel Camarena; Alejandra Ramirez-Venegas; Manuel Castillejos-López; Martha Pérez-Rodríguez; César González-Bonilla; Concepción Grajales-Muñíz; Víctor Borja-Aburto; Juan Manuel Mejía-Aranguré
Journal:  BMC Infect Dis       Date:  2012-11-13       Impact factor: 3.090

7.  A Simple PCR-RFLP Method for Genetic Phase Determination in Compound Heterozygotes.

Authors:  Rodney T Perry; Harsh Dwivedi; Brahim Aissani
Journal:  Front Genet       Date:  2012-01-13       Impact factor: 4.599

Review 8.  Four genetic polymorphisms of lymphotoxin-alpha gene and cancer risk: a systematic review and meta-analysis.

Authors:  Yi Huang; Xi Yu; Lingyan Wang; Shengjun Zhou; Jie Sun; Nan Feng; Sheng Nie; Jingmi Wu; Feng Gao; Bing Fei; Jianyong Wang; Zhiqing Lin; Xianru Li; Leiting Xu; Xiang Gao; Meng Ye; Shiwei Duan
Journal:  PLoS One       Date:  2013-12-12       Impact factor: 3.240

9.  The association between the polymorphisms of TNF-α and non-Hodgkin lymphoma: a meta-analysis.

Authors:  Yong-Qiao He; Jin-Hong Zhu; Shao-Yi Huang; Zhuo Cui; Jing He; Wei-Hua Jia
Journal:  Tumour Biol       Date:  2014-09-10

10.  SNP screening of central MHC-identified HLA-DMB as a candidate susceptibility gene for HIV-related Kaposi's sarcoma.

Authors:  B Aissani; A K Boehme; H W Wiener; S Shrestha; L P Jacobson; R A Kaslow
Journal:  Genes Immun       Date:  2014-07-10       Impact factor: 2.676

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.